scholarly journals Review of Novel Clinical Recommendations on Diagnosis and Treatment of Atrial Fibrillation (2016) of the European Society of Cardiology Developed in Collaboration With the European Association for Car dio-Thor acic Surgery

Kardiologiia ◽  
2017 ◽  
Vol 17 (7) ◽  
pp. 90-96
Author(s):  
A. L. Syrkin ◽  
◽  
F. Y. Kopylov ◽  
G. G. Ivanov ◽  
M. V. Serova ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
European Society ◽  
European Association ◽  
Diagnosis And Treatment ◽  
Clinical Recommendations ◽  
European Society Of Cardiology

scholarly journals Atrial fibrillation: review of the European Society of Cardiology guidelines and national guidelines 2020

2020 ◽  
pp. 21-29
Author(s):  
Natalia S. Mescherina ◽  
Elena M. Khardikova ◽  
Igor A. Saraev
Keyword(s):  
Atrial Fibrillation ◽  
European Society ◽  
Stroke Risk ◽  
Diagnosis And Treatment ◽  
Russian Society ◽  
Thromboembolic Complications ◽  
National Guidelines ◽  
European Society Of Cardiology ◽  
Risk Symptom

The review presents the key provisions of the recommendations of the Russian society of cardiology and the guidelines of the European society of cardiology for the diagnosis and treatment of atrial fibrillation (AF), updated in 2020. The recommendations clearly state the requirements for atrial fibrillation diagnosis verification, and propose an approach to the formation of a complex characteristic of the disease in four positions, which is designated as 4S-AF (Stroke risk, Symptom severity, Severity of AF burden, Substrate severity). The authors analyzed the strategy "CC To ABC" (Confirm AF, Characterize AF, Treat AF: the ABC pathway) proposed by European experts, the issues of modern terminology and requirements for verifying the diagnosis of AF, complex characteristics of the disease and stratification of the risk of stroke and bleeding, a new ABC approach in the treatment of AF, where A is anticoagulant prevention of thromboembolic complications, B is the control of symptoms of the disease and C is the detection and treatment of comorbid pathology. The General principles that have changed in comparison with the previous versions of guidelines of 2016 on the initiation and tactics of anticoagulant therapy, pharmacological and non-drug cardioversion, catheter ablation in patients with AF, affecting the prognosis and outcomes in patients with AF, are outlined. It is emphasized that the pattern of atrial fibrillation (first diagnosed, paroxysmal, persistent, long-term persistent, permanent) should not determine the indications for anticoagulant prevention. The solution to this issue is determined by the level of risk according to the CHA2DS2-VASc scale. The introduction of the considered methods of diagnosis and treatment of AF into clinical practice will optimize the burden on the health care system and reduce the costs associated with the burden of AF.

2020 guidelines for the diagnosis and management of atrial fibrillation

2020 ◽  
Vol 15 (12) ◽  
pp. 1-6
Author(s):  
Belinda Linden
Keyword(s):  
Atrial Fibrillation ◽  
Thoracic Surgery ◽  
European Society ◽  
European Association ◽  
Diagnosis And Management ◽  
European Society Of Cardiology ◽  
Cardiovascular Nursing

Belinda Linden presents a quarterly overview of recently published guidance of relevance to cardiovascular nursing. This update reviews the 2020 guidelines from the European Society of Cardiology and the European Association of Cardio-Thoracic Surgery regarding the diagnosis and management of atrial fibrillation.

scholarly journals Antiarrhythmic therapy for atrial fibrillation: current guidelines of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery (ESC/EACTS)

2021 ◽  
Vol 20 (5) ◽  
pp. 2962
Author(s):  
A. I. Tarzimanova ◽  
V. L. Doshchitsin
Keyword(s):  
Atrial Fibrillation ◽  
Thoracic Surgery ◽  
European Society ◽  
Rate Control ◽  
European Association ◽  
Rhythm Control ◽  
Ventricular Rate ◽  
Thromboembolic Events ◽  
Increased Risk ◽  
European Society Of Cardiology

The treatment of atrial fibrillation (AF) remains one of the most difficult tasks in modern cardiology. In 2020, the European Society of Cardiology (ESC), together with the European Association for Cardio-Thoracic Surgery (EACTS), published guidelines for the diagnosis and management of AF, which include several new directives.ESC experts have formulated a novel concept for treatment of AF patients. The first component of treatment ‘A' (Anticoagulation/ Avoid stroke) is anticoagulant therapy in patients with increased risk of thromboembolic events. The second line of treatment ‘B' (Better symptom control) is the control of arrhythmia symptoms, selection of a rhythm control strategy or ventricular rate control. The third direction ‘C' includes cardiovascular risk factors and comorbid conditions management.The most challenging tasks in AF treatment are the control of arrhythmia symptoms. As in the previous version of 2016 guidelines, the latest ones identify 2 following strategies in treatment of AF: rhythm control and ventricular rate control.According to the current ESC/EACTS guidelines (2020), antiarrhythmic therapy continues to be one of the important directions in AF management. Early prescription f antiarrhythmic and anticoagulant agents with an increased risk of thromboembolic events, catheter ablation can not only improve the quality of life, but also the prognosis of patients with AF.

Nonpermanent atrial fibrillation in the new European Society of Cardiology guidelines

2021 ◽  
Author(s):  
Eduardo Vázquez Ruiz de Castroviejo ◽  
Antonio Linde Estrella ◽  
Francisco Manuel García García ◽  
Juan Carlos Fernández Guerrero
Keyword(s):  
Atrial Fibrillation ◽  
European Society ◽  
European Society Of Cardiology
Sign in / Sign up

Export Citation Format

Share Document